L-Cysteine.
Sulfur amino acid essential for hair, nails, and glutathione It's the sulfur amino acid your body builds glutathione from, and the rate-limiting one of the three. It also feeds keratin, the protein hair and nails are made of.
Reviewed March 2026
- Category
- Amino acid
- Also filed under
- Glutathione PrecursorHair HealthNail Strength
What L-Cysteine is, and what it does.
- Does it work
- Suits people building a daily routine around glutathione status, and anyone working on nail and hair strength across months. It also feeds taurine and coenzyme A.
- How much to take
- Start with 250mg to 500mg a day, the band a daily cysteine sits in. Free amino acids are absorbed more reliably on an empty stomach.
- Time to feel it
- Glutathione status responds within days to a couple of weeks, and that lands on a lab measure. Hair and nail changes need a few months of turnover to show.
- The first dose
- Quiet. Cysteine goes straight into glutathione synthesis, so the first dose reads in redox chemistry rather than as anything you'd feel.
- With regular use
- Weeks of daily use keep the rate-limiting substrate for glutathione supplied. Over several months it also feeds keratin, which is where nail and hair strength shows up.
- How well tolerated
- Well tolerated at the daily band. Higher amounts can bring a sulfur smell or stomach upset. Check with your doctor first if you're pregnant, breastfeeding or on prescription medicine.
- How it feels
- Not a felt ingredient. The work happens in redox chemistry and slow protein turnover, so you read it on a panel or in how your nails hold up over months.
- The overlooked benefit
- Most of your taurine is made from cysteine, and it also donates the sulfur for the iron-sulfur clusters your respiratory enzymes are built around.
250 to 500mg a day is where L-Cysteine works.
Source: Nimni et al., Nutr Metab 2007; general amino acid supplementation data
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
L-Cysteine has emerging evidence. Based on 61530+ studies.
- Glutathione synthesis as the rate-limiting substrateNarrative review
- Taurine production through cysteine dioxygenaseNarrative review
- Coenzyme A assemblyNarrative review
- Keratin disulfide structure in hair and nailsNarrative review
- Antioxidant defence and redox balanceRandomised trial
- Iron-sulfur cluster assembly in respiratory enzymesNarrative review
Questions people ask about L-Cysteine.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Glutathione is assembled from cysteine, glutamate and glycine, with cysteine as the limiting input and glycine required to finish the tripeptide. Providing both covers the substrate demand at each ligation step.
Glutamine converts to glutamate, the third residue of the glutathione tripeptide, so it pairs naturally with the cysteine that limits the pathway. Together with glycine the three cover the full amino acid requirement for normal glutathione turnover.
Selenium is built into glutathione peroxidase as selenocysteine, and that enzyme spends glutathione as its reducing substrate. L-cysteine supplies the glutathione side of the same normal redox cycle.
Ascorbate and glutathione regenerate each other in the cell, with glutathione reducing oxidized ascorbate back to its active form. Cysteine keeps the glutathione pool stocked, which is what lets that recycling loop keep running.
Cysteine catabolism produces sulfite, which the molybdenum enzyme sulfite oxidase converts to sulfate. Sulfur amino acid load and molybdenum status belong to one disposal route.
Pyridoxal 5-phosphate runs cystathionine beta-synthase and gamma-lyase, which produce cysteine, and cysteine sulfinate decarboxylase, which uses it. Both directions of cysteine handling need B6.
L-cysteine is oxidised to cysteine sulfinate and then decarboxylated toward hypotaurine and taurine. Providing taurine directly leaves more cysteine free for glutathione synthesis.
Cysteine availability is what limits glutathione synthesis, since glycine and glutamate are rarely short. Dosing precursor and tripeptide together loads the same pool from two directions.
Glutathione reductase is an FAD flavoenzyme that regenerates reduced glutathione from its disulfide. Riboflavin status sets how many times each cysteine-derived molecule cycles.
Dihydrolipoate reduces extracellular cystine to cysteine, which uses a faster transporter than cystine. The intracellular pool for glutathione synthesis rises as a result.
Betaine methylates homocysteine through BHMT and returns it to methionine rather than committing it to transsulfuration and cysteine. Supplemental cysteine covers the arm betaine pulls away from.
Methionine synthase needs methylcobalamin to remethylate homocysteine, the alternative fate to cysteine synthesis. The two arms of that junction are considered together.
5-methyltetrahydrofolate supplies the methyl group for homocysteine remethylation, competing with the route that yields cysteine. Cysteine intake and folate status act on opposite arms of one node.
SAM-e demethylation produces homocysteine, the entry point of transsulfuration to cysteine, and SAM-e allosterically activates cystathionine beta-synthase. It sits directly upstream of endogenous cysteine formation.
Cysteine-containing peptides reduce ferric to ferrous iron and keep it soluble at intestinal pH, the mechanism behind the meat factor. Non-heme iron uptake rises, much as it does with ascorbate.
Metallothionein holds zinc in cysteine thiol clusters, so cysteine supply is part of intracellular zinc buffering. Sulfur amino acid intake and zinc handling are linked.
MSM adds organic sulfur toward the sulfate pool used in conjugation and connective tissue. It runs alongside cysteine rather than replacing it, since only cysteine feeds glutathione synthesis.
Free thiols reduce and chelate copper into complexes that lower its availability in solution. A large thiol dose in the same serving holds copper back.
Methionine is converted to S-adenosylmethionine, then to homocysteine, which condenses with serine to form cystathionine and is cleaved to cysteine. Cysteine is therefore conditionally essential: adequate methionine plus a functioning transsulfuration pathway makes it, and supplemental cysteine spares methionine for methylation. The relationship runs one way only, since cysteine cannot be converted back to methionine.
Serine is the obligate partner substrate in the first committed step of transsulfuration, where cystathionine beta-synthase joins it to homocysteine. Without serine that step does not proceed, whatever the homocysteine supply. This is a fixed feature of the pathway rather than a dose-dependent interaction.
Coenzyme A synthesis requires cysteine as the sulfhydryl donor, condensed onto phosphopantothenate by phosphopantothenoylcysteine synthetase. The reactive thiol at the business end of coenzyme A comes from cysteine. Both substrates are required, which is why the pair sits together in energy-metabolism formulation.
Cysteine supplies the rate-limiting substrate for glutathione synthesis, but keeping glutathione in its reduced form depends on glutathione reductase, which runs on NADPH. NADP is built from nicotinamide derived from niacin. Substrate supply and regeneration capacity are two separate requirements, and this row is the second one.
Alpha-tocopherol quenches lipid peroxyl radicals in membranes and becomes a tocopheryl radical, which ascorbate reduces back to the active form. Ascorbate is then regenerated at the expense of glutathione, for which cysteine is the rate-limiting precursor. The three sit in a defined chain, so lipid-phase and aqueous-phase capacity are linked rather than independent.
N-acetylcysteine carries an acetyl group on the amino nitrogen, which improves its stability against oxidation to cystine compared with free cysteine. After absorption, deacetylation releases cysteine into the same pool. Anyone taking both is contributing to one cysteine pool, so total intake should be counted together rather than separately.
Sulforaphane modifies KEAP1 cysteine residues, releasing Nrf2 to induce antioxidant response element genes including both subunits of glutamate cysteine ligase. Raising the enzyme without raising its substrate limits what the induction can produce, and cysteine is that substrate. The mechanism is well characterised in cell and animal work; a joint human trial is a separate question.
Homocysteine sits at a branch point, either remethylated back to methionine or committed down transsulfuration toward cysteine. Choline, through betaine, feeds the remethylation branch via betaine homocysteine methyltransferase. Adding cysteine or its precursors alters the pull on that same node, so the two ingredients act on opposite arms of one junction.
Whey protein carries more cysteine per gram than most food proteins, delivered as cystine within intact protein. That is the mechanistic reason whey is described as a glutathione-supporting protein source. Heat processing that denatures the protein does not destroy the amino acid, though it does change the disulfide arrangement.
The liver is the main site of glutathione synthesis and export, and silymarin is described in preclinical work as supporting hepatic glutathione status. Cysteine supplies the rate-limiting amino acid for that synthesis. The pairing is mechanistically coherent; the human combination data is thin and should not be read as an outcome.
Curcuminoids activate Nrf2 signalling, which raises transcription of glutathione synthesis enzymes among other antioxidant response genes. As with sulforaphane, that induction depends on cysteine availability to be expressed as actual glutathione. Curcumin's own low oral bioavailability is the limiting factor on how much of this reaches tissue.
Nothing specific on file for L-Cysteine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What L-Cysteine actually does.
Glutathione is built from three amino acids, and cysteine is the one usually in short supply, so it sets the pace.
The body can make cysteine from methionine, using two enzymes that both need vitamin B6.
Cysteine's sulfur group can pair up with another one, and that pairing is how proteins hold their shape.
Cysteine is the raw material the body uses to make taurine.
Where L-Cysteine comes from.
Cysteine is made either by feeding sugar to bacteria that produce it, or by breaking down keratin-rich material with acid. Both give the same amino acid. If the source matters to you, the fermentation route is the one declared vegetarian or vegan.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
The fermentation route starts from a plant sugar feedstock such as glucose from maize or cane. The older hydrolysis route starts from keratin-rich material, historically human hair, poultry feathers or hog bristle, which is why the animal origin question is asked about this ingredient at all.
In the fermentation route, engineered Escherichia coli or Corynebacterium glutamicum strains are grown on sugar and secrete cysteine or cystine, which is drawn from the broth. In the hydrolysis route, keratin is boiled in strong hydrochloric acid to break the protein into free amino acids, releasing cystine from its disulfide-rich structure.
Cystine is the least soluble amino acid present in either stream and is recovered by pH-adjusted crystallisation. It is then reduced, chemically or electrolytically, to the free cysteine thiol.
Ion exchange chromatography separates cysteine from other amino acids and from residual salts, with activated carbon used for decolourisation. Hydrolysate-derived material carries a heavier purification burden because the starting mixture is more complex.
Free cysteine may be crystallised as the hydrochloride monohydrate for stability, left as cystine, or acetylated with acetic anhydride to give N-acetylcysteine.
Material is specified on assay, on specific rotation to confirm the L-isomer, and on residual solvents and heavy metals. Fermentation-derived material is normally declared as vegetarian or vegan; hydrolysate-derived material is not.
Supplied as a white crystalline powder, encapsulated or blended. Because the free thiol oxidises in air, packaging and moisture control matter more here than for most amino acids.
Getting L-Cysteine from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In a small crossover trial in 19 healthy men given alcohol, 1,200 mg of L-cysteine taken alongside the drinking was associated with less next-day nausea and headache, and 600 mg with lower reported stress and anxiety, on correlational analysis.Randomised trial. Eriksson et al., 2020 (Alcohol and Alcoholism). PMID 32808029 ↗
- In a placebo-controlled pilot trial in 165 adults with low vitamin D status, adding 1,000 mg of L-cysteine daily to 2,000 IU of vitamin D for 6 months raised bioavailable 25-hydroxyvitamin D in both sexes and lowered C-reactive protein and the neutrophil-to-lymphocyte ratio compared with vitamin D alone.Randomised trial. Jain et al., 2024 (BMJ Nutrition, Prevention and Health). PMID 39882299 ↗
- A network meta-analysis ranking nutritional supplements by their effect on circulating homocysteine in healthy adults; homocysteine is a metabolic marker, not a clinical outcome.Systematic review. Liu C et al., 2025 (Nutrition Reviews). PMID 39960689 ↗
- Pooled trials of combined B-vitamin supplementation report lowering of homocysteine, with vascular endpoints analysed separately; the marker and the endpoint are not the same result.Meta-analysis. Guo L et al., 2026 (Annals of Medicine). PMID 41615824 ↗
- L-cysteine supplementation raised glutathione and adiponectin in cells exposed to high glucose, with supporting rodent data in the same report; these are biochemical markers in models, not human outcomes.In vitro study. Achari AE et al., 2017 (Archives of Biochemistry and Biophysics). PMID 28755973 ↗
- A single-patient account of L-cysteine supplementation in a rare inherited mitochondrial tRNA-modification disorder; one patient cannot establish an effect.Case report. Soler-Alfonso C et al., 2019 (Molecular Genetics and Metabolism Reports). PMID 30740308 ↗
- A review of the mechanistic case for lowering homocysteine through cysteine and related nutrient supply, drawing chiefly on preclinical and biomarker data.Narrative review. Jain SK et al., 2024 (Antioxidants and Redox Signaling). PMID 37756366 ↗
- Multi-species bioinformatic analysis links dysregulated cysteine metabolism to ferroptosis signatures in joint tissue; this is computational and tissue-level, not an intervention result.In vitro study. Zheng L et al., 2026 (Journal of Orthopaedic Translation). PMID 42471866 ↗
- Zinc combined with N-acetyl-L-cysteine reduced markers of cadmium-induced red cell damage in this animal model; the pairing was assessed in animals only.Animal study. Zhang D et al., 2018 (Ecotoxicology and Environmental Safety). PMID 30059877 ↗
- Cysteine added during in vitro maturation improved bovine oocyte developmental competence, attributed by the authors to improved redox handling in the culture medium.Animal study. Zhang X et al., 2026 (Biology). PMID 42345829 ↗
- A folic acid and creatine trial characterising metabolic signatures of arsenic handling, in which cysteine-related metabolites appear within the broader metabolomic panel.Randomised trial. Li W et al., 2025 (Environmental Science and Technology). PMID 40668877 ↗
These are the studies our verdict leans on, chosen from the 1,069 we read for L-Cysteine. The full linked list is below.
The studies, linked.
2 sources behind our L-Cysteine verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialPhase III Study of L-Cysteine in Patients With Erythropoietic ProtoporphyriaClinicalTrials.gov ↗PHASE3 · 50 participants · Completed
- Clinical trialHigh-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure-A Prospective Randomized Pilot TrialClinicalTrials.gov ↗NA · 40 participants · Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 690 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular L-Cysteine is, not how risky it is. A report is not proof L-Cysteine caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.